Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunization schedules for influenza.

E A Marcus, K S Liem, F E André

    Developments in Biological Standardization
    |January 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Differential cytokine and chemokine expression during rejection and infection following intestinal transplantation.

    Transplant immunology·2021
    Same author

    Editorial: control of acid secretion.

    Alimentary pharmacology & therapeutics·2018
    Same author

    Corrigendum. The binding selectivity of vonoprazan (TAK-438) to the gastric H+,K+-ATPase.

    Alimentary pharmacology & therapeutics·2016
    Same author

    The binding selectivity of vonoprazan (TAK-438) to the gastric H+, K+ -ATPase.

    Alimentary pharmacology & therapeutics·2015
    Same author

    Colloidal bismuth subcitrate impedes proton entry into Helicobacter pylori and increases the efficacy of growth-dependent antibiotics.

    Alimentary pharmacology & therapeutics·2015
    Same author

    'Virtual lesion' in pain research; a study on magnetic stimulation of the primary motor cortex.

    European journal of pain (London, England)·2015
    Same journal

    International challenges and public policy issues.

    Developments in biological standardization·2000
    Same journal

    Regulation of biologicals in China.

    Developments in biological standardization·2000
    Same journal

    ICH activities on biotech topics.

    Developments in biological standardization·2000
    Same journal

    Regulation of biologicals in the European Union.

    Developments in biological standardization·2000
    Same journal

    Standardisation and licensing of combination vaccines based on DTP.

    Developments in biological standardization·2000
    Same journal

    Control of foot-and-mouth disease by vaccination.

    Developments in biological standardization·2000
    See all related articles

    Influenza vaccination has not prevented epidemics despite individual benefits. Large-scale, coordinated immunization programs are needed to impact community spread and reduce influenza

    Area of Science:

    • Epidemiology
    • Immunology
    • Public Health

    Background:

    • Influenza vaccination has demonstrated individual benefits but failed to prevent widespread epidemics over the past 30 years.
    • National morbidity and mortality statistics show disappointing impacts of vaccination programs.
    • The effectiveness of influenza immunization in controlling disease spread in open communities remains a challenge.

    Purpose of the Study:

    • To discuss the reasons behind the limited impact of influenza vaccination on epidemic control.
    • To identify key populations for targeted influenza immunization to minimize disease burden.
    • To assess current influenza vaccine types, administration methods, and their respective advantages and disadvantages.

    Main Methods:

    • Review of historical influenza vaccination data and epidemiological trends.

    Related Experiment Videos

  • Analysis of factors contributing to the lack of epidemic prevention through vaccination.
  • Assessment of vaccine efficacy, administration routes, and logistical challenges.

    • Main Results:

    • Influenza vaccination has not been implemented on a scale sufficient to affect virus spread in open communities.
    • Specific population groups requiring focused immunization strategies were identified.
    • Current vaccine types and administration methods were evaluated for their effectiveness and limitations.

    Conclusions:

    • Systematic application of existing knowledge and technologies is likely to be more impactful than solely focusing on increasing vaccine efficacy.
    • Key deficiencies include challenges in rapid vaccine production and a general reluctance towards annual, large-scale immunization programs.
    • Resolving logistic and administrative issues through long-term, coordinated planning between health authorities and vaccine manufacturers is crucial for improving influenza control.